E-LIB Suche - Ergebnisse für: Railean, Violeta

1

Mutation-class dependent signatures outweigh disease-associ..:

Santos, Lúcia ; Nascimento, Rui ; Duarte, Aires...
Cell & Bioscience. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

2

Synthesis and the In Vitro Evaluation of Antitumor Activity..:

Álvaro-Martins, Maria João ; Railean, Violeta ; Martins, Filomena...
Molecules. 28 (2023) 4 - p. 1877 , 2023

Link: https://doi.org/10.3390/..

3

Personalized medicine: Function of CFTR variant p.Arg334Trp..:

Railean, Violeta ; Rodrigues, Cláudia S. ; Ramalho, Sofia S....
Frontiers in Molecular Biosciences. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Drug Repurposing for Cystic Fibrosis: Identification of Dru..:

Rodenburg, Lisa W. ; Delpiano, Livia ; Railean, Violeta...
International Journal of Molecular Sciences. 23 (2022) 20 - p. 12657 , 2022

Link: https://doi.org/10.3390/..

5

The SLC26A9 inhibitor S9‐A13 provides no evidence for a rol..:

Jo, Sungwoo ; Centeio, Raquel ; Park, Jinhong...
The FASEB Journal. 36 (2022) 11 - p. , 2022

Link: https://doi.org/10.1096/..

6

Systems Approaches to Unravel Molecular Function: High-cont..:

Pinto, Madalena C. ; Botelho, Hugo M. ; Silva, Iris A.L....
Journal of Molecular Biology. 434 (2022) 5 - p. 167436 , 2022

Link: https://doi.org/10.1016/..

7

Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9:

Pinto, Madalena C. ; Quaresma, Margarida C. ; Silva, Iris A. L....
International Journal of Molecular Sciences. 22 (2021) 23 - p. 13064 , 2021

Link: https://doi.org/10.3390/..

8

Personalized Medicine Based on Nasal Epithelial Cells: Comp..:

Silva, Iris A. L. ; Railean, Violeta ; Duarte, Aires.
Journal of Personalized Medicine. 11 (2021) 5 - p. 421 , 2021

Link: https://doi.org/10.3390/..

9

Organoids as a personalized medicine tool for ultra-rare mu..:

Silva, Iris A.L. ; Doušová, Tereza ; Ramalho, Sofia...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866 (2020) 11 - p. 165905 , 2020

Link: https://doi.org/10.1016/..

10

Mutant CFTR Drives TWIST1 mediated epithelial–mesenchymal t..:

Quaresma, Margarida C. ; Pankonien, Ines ; Clarke, Luka A....
Cell Death & Disease. 11 (2020) 10 - p. , 2020

Link: https://doi.org/10.1038/..

11

TMEM16A chloride channel does not drive mucus production:

Simões, Filipa B ; Quaresma, Margarida C ; Clarke, Luka A...
Life Science Alliance. 2 (2019) 6 - p. e201900462 , 2019

Link: https://doi.org/10.26508..

12

Synthesis and the In Vitro Evaluation of Antitumor Activity..:

Álvaro-Martins, Maria João ; Railean, Violeta ; Martins, Filomena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963285/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Synthesis and the in vitro evaluation of antitumor activity..:

Álvaro Martins, Maria Joao ; Railean, Violeta ; Martins, Filomena...
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00100%2F2020/PT. , 2023

Link: http://hdl.handle.net/10..

14

Drug Repurposing for Cystic Fibrosis: Identification of Dru..:

Rodenburg, Lisa W ; Delpiano, Livia ; Railean, Violeta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603984/. , 2022

Link: http://www.ncbi.nlm.nih...

15

The SLC26A9 inhibitor S9-A13 provides no evidence for a rol..:

Jo, Sungwoo ; Centeio, Raquel ; Park, Jinhong...
https://mediatum.ub.tum.de/1693400. , 2022

Link: https://mediatum.ub.tum...